120 related articles for article (PubMed ID: 1086131)
1. Active T-rosette-forming cells in the peripheral blood of cancer patients.
Kerman RH; Smith R; Stefani SS; Ezdinili EZ
Cancer Res; 1976 Sep; 36(9 pt.1):3274-8. PubMed ID: 1086131
[TBL] [Abstract][Full Text] [Related]
2. Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases.
Wybran J; Fudenberg HH
J Clin Invest; 1973 May; 52(5):1026-32. PubMed ID: 4540711
[TBL] [Abstract][Full Text] [Related]
3. Peripheral lymphocyte count and suppopulations of T and B lymphocytes in benign and malignant diseases.
Lee YT
Surg Gynecol Obstet; 1977 Mar; 144(3):435-50. PubMed ID: 300179
[TBL] [Abstract][Full Text] [Related]
4. Immune function in patients with multiple myeloma (delayed cutaneous reactivity and lymphocytes bearing receptors for sheep, human and mouse erythrocytes).
Dammacco F; Miglietta A; Bonomo L
Ric Clin Lab; 1977; 7(4):343-53. PubMed ID: 307801
[TBL] [Abstract][Full Text] [Related]
5. Cellular immunity in patients with epidermoid cancer of the head and neck.
Papenhausen PR; Kukwa A; Croft CB; Borowiecki B; Silver C; Emeson EE
Laryngoscope; 1979 Apr; 89(4):538-49. PubMed ID: 311881
[TBL] [Abstract][Full Text] [Related]
6. The comparison of different rosette assay systems for the determination of T-lymphocytes in patients with solid malignant tumors.
Gramatzki M; Kalden JR
Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):104-17. PubMed ID: 311555
[TBL] [Abstract][Full Text] [Related]
7. Mutual relationship between total and active T lymphocytes in patients with malignant tumors.
Babusíková O; Babusík P; Novotná L
Neoplasma; 1978; 25(1):67-74. PubMed ID: 305544
[TBL] [Abstract][Full Text] [Related]
8. [Influence of the localization on the prognostic value of E, E-active and autologous rosettes in lung, esophagus and otorhinolaryngologic cancer].
Youinou P; Miossec P; Labat JP; Clavier J; Coatalem M; Guillerm D; Kerbrat G
Sem Hop; 1983 Dec; 59(44):3033-7. PubMed ID: 6320389
[TBL] [Abstract][Full Text] [Related]
9. T and B lymphocytes in myasthenia gravis.
Itoyama Y; Kawanami S; Goto I; Kuroiwa Y
Clin Exp Immunol; 1979 Sep; 37(3):452-6. PubMed ID: 315844
[TBL] [Abstract][Full Text] [Related]
10. E rosettes in the uranium miners with lung cancer.
Kudrna K; Andrlíková J; Smíd A; Stipl Z
Czech Med; 1979; 2(3):141-7. PubMed ID: 231508
[TBL] [Abstract][Full Text] [Related]
11. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
12. Formation of total and stable E-rosettes by lymphocytes from patients with pulmonary tuberculosis stimulated by Con A or PPD.
Aristizábal L; García LF
J Clin Lab Immunol; 1985 Jan; 16(1):31-6. PubMed ID: 3981616
[TBL] [Abstract][Full Text] [Related]
13. Comparison of interleukin-12 with lung cancer and malignant lymphoma undergoing autologous peripheral blood stem cell transplantation.
Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Yamaguchi K; Fukuhara S
J Cancer Res Clin Oncol; 2002 Jan; 128(1):29-36. PubMed ID: 11862469
[TBL] [Abstract][Full Text] [Related]
14. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.
Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
Clin Cancer Res; 2004 Jun; 10(11):3755-62. PubMed ID: 15173082
[TBL] [Abstract][Full Text] [Related]
15. The active E rosette test: correlation with delayed cutaneous hypersensitivity.
Felsburg PJ; Edelman R; Bilman RH
J Immunol; 1976 Apr; 116(4):1110-4. PubMed ID: 1082906
[TBL] [Abstract][Full Text] [Related]
16. Active rosette forming cells as a possible functional subpopulation of human peripheral T lymphocytes.
Harada M; Ishino C; Mori T; Hattori K
Jpn J Exp Med; 1977 Dec; 47(6):489-94. PubMed ID: 305494
[TBL] [Abstract][Full Text] [Related]
17. A pilot clinical trial of the toxicity and immunorestorative effects of T cell reconstituting factor (SR 270258) in immunosuppressed cancer patients.
Murray JL; Reuben JM; Smith TL; Gehan EA; Koretz SM; Hersh EM
J Biol Response Mod; 1987 Feb; 6(1):56-68. PubMed ID: 2951501
[TBL] [Abstract][Full Text] [Related]
18. Rosette forming T-cells in human lymphomas: relationship with age and clinical parameters.
Carosella ED; Braun M; Suarez A; Pavlovsky A; Bachmann AE
Biomedicine; 1976 Sep; 25(8):285-7. PubMed ID: 793647
[TBL] [Abstract][Full Text] [Related]
19. Graves' ophthalmopathy--immunologic parameters related to corticosteroid therapy.
Sergott RC; Felberg NT; Savino PJ; Blizzard JJ; Schatz NJ
Invest Ophthalmol Vis Sci; 1981 Feb; 20(2):173-82. PubMed ID: 6970185
[TBL] [Abstract][Full Text] [Related]
20. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
